SVFC News .45 IntelliCell Opens New Flagship Medical Facility

2012-06-04 08:30 ET - News Release

NEW YORK, June 4, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC) announced today that it has opened its new Tissue Processing Laboratory medical facility at 460 Park Avenue, 17th floor, New York, NY, in conjunction with the ReGen Medical, PC medical practice.  As a measure of its commitment to be compliant with the FDA, IntelliCell is engaged with biologics and legal experts to assist the Company with compliance issues related to applicable federal and state regulations. IntelliCell has implemented a new Quality Assurance (QA) unit by employing a new QA director with 10 years of experience in cellular tissue management to assist with IntelliCell's compliance-oriented approach.  IntelliCell is also working with Biologics Consulting Group (BCG) and the Buchanan Ingersoll & Rooney legal team to continue to work on its policies and procedures to be compliant with the FDA.

Dr. Steven Victor, CEO of IntelliCell, stated, "It is an exciting moment for IntelliCell and its affiliate, ReGen Medical, PC, to finally move into its new state-of-the-art facility.  It has taken a year to build out the new space which consists of 2 quad AAAA operating rooms and a new Tissue Processing Laboratory."